Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patient…
Biotechnology
US, Research Triangle Park [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Fennec Pharmaceuticals Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDFennec Pharmaceuticals Inc. can't present revenue by segment